Cargando…
Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
BACKGROUND: A single-daily dose of 75 mg of acetylsalicylic acid inhibits 100% of thromboxane-B2 synthesis within 30–60 min. Thromboxane-B2 synthesis then recovers slowly as new platelets are released from the bone marrow. Normally, only 10% of the platelets are replaced daily by new platelets enter...
Autores principales: | Hegde, Nischal N., Mathew, Navin, Thachathodiyl, Rajesh, Menon, Jaideep C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551163/ https://www.ncbi.nlm.nih.gov/pubmed/36237906 http://dx.doi.org/10.3389/fcvm.2022.1004473 |
Ejemplares similares
-
Compliance to secondary prevention strategies for coronary artery disease: a hospital-based cross-sectional survey from Ernakulam, South India
por: Sudevan, Remya, et al.
Publicado: (2020) -
Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial
por: Willems, Loes H., et al.
Publicado: (2022) -
Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Liu, Di, et al.
Publicado: (2023) -
Fluorodeoxyglucose-positron emission tomography (FDG-PET) of carotid arteries and non-alcoholic fatty liver disease (NAFLD): An analytical cross-sectional study from a teaching hospital, Kerala, South India
por: Rane, Sameer, et al.
Publicado: (2022) -
Optical Coherence Tomography: An Eye Into the Coronary Artery
por: Gupta, Ankush, et al.
Publicado: (2022)